Canada's "national" newspaper, the Globe and Mail, does an annual analysis of Canadian corporate governance rankings called "Board Games". For the 2013 ranking, Valeant Pharmaceuticals came in the middle of the pack, #100 out of 232 Canadian companies. Valeant lost points for not splitting CEO and Chairman of the Board, for not including a significant number of women as board directors, and for not making full public disclosures on a variety of governance subjects.
(For the curious, a Canadian company that came in almost dead last --#229 out of 232 companies-- was CGI Group, the folks who brought you the rollout of the online application process for The Affordable Care Act last October.)